Anna Maria Paoletti

Prof. Anna Maria Paoletti


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
APAnna Maria Paoletti
Anna Maria Paoletti
SRSandra Romagnino
Sandra Romagnino
RCRossana Contu
Rossana Contu
MOMarisa Margherita Orrù
Marisa Margherita Orrù
MMMaria Francesca Marotto
Maria Francesca Marotto
GMGian Benedetto Melis
Gian Benedetto Melis

1 March 2004 in Fertility and Sterility
Verified
Journal Article
Closed access
APAnna Maria Paoletti
Anna Maria Paoletti
SLStefano Lello
Stefano Lello
SFStefania Fratta
Stefania Fratta
MOMarisa Orrù
Marisa Orrù
FRFrancesca Ranuzzi
Francesca Ranuzzi
GMGian Benedetto Melis
Gian Benedetto Melis

26 August 2019 in Expert Opinion on Pharmacotherapy
Verified
Journal Article
Closed access
Manuela NeriManuela Neri
Manuela Neri
MPMichele Peiretti
Michele Peiretti
GMGian Benedetto Melis
Gian Benedetto Melis
BPBruno Piras
Bruno Piras
VVValerio Vallerino
Valerio Vallerino
Valerio MaisValerio Mais
Valerio Mais
Introduction: Endometrial cancer (EC) is one of the most frequent gynecological cancers worldwide. The gold standard treatment of EC is most certainly surgery and may very well be the only therapy in the early stages of disease. To improve outcomes in non-early EC, adjuvant therapy is often employed but this is not standardized. Adjuvant options can include radiotherapy, chemotherapy or a combination of both. Adjuvant chemotherapy could be indicated in high-risk stage I and II or advanced stage EC. Several clinical trials are ongoing in an attempt to define the optimal adjuvant treatment. Furthermore, chemotherapy is the front-line therapy in advanced unresectable, metastatic or recurrent endometrial cancer. Areas covered: Herein, the authors review the first-line chemotherapy for the treatment of endometrial cancer and provide their expert perspectives on these therapies. Expert opinion: Chemotherapy is fundamental in advanced/recurrent EC. Further evidence is needed to characterize the role of adjuvant chemotherapy. Future studies should consider genomic and molecular heterogeneities to identify even more efficient tailored therapies.

25 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ACAngelo Cagnacci
Angelo Cagnacci
IGIrene Gazzo
Irene Gazzo
SSSara Stigliani
Sara Stigliani
APAnna Maria Paoletti
Anna Maria Paoletti
PAPaola Anserini
Paola Anserini
AXAnjeza Xholli
Anjeza Xholli
The effect of estrogen and progesterone on oxidative status is not yet very clear, improvements and detrimental effects having been reported with the use of menopausal hormone therapy or hormonal contraceptives, respectively. In this study, we evaluated the role played by estrogen and progesterone separately, on the oxidative status of 32 women, 18 to 43 years old, by inducing high levels of estrogen and then adding high levels of progesterone. During a cycle of in vitro fertilization, blood samples were collected prior to gonadotrophin stimulation (low estradiol levels), on the day of oocyte retrieval (high levels of estrogen), and on the day of embryo transfer (high levels of estrogen and progesterone). Total blood levels of oxidants (FORT), antioxidants (FORD), and their ratio FORT/FORD were measured using a colorimetric method based on the Fenton reaction. Seven women measured their early morning body temperature at the same time points. FORT significantly decreased from the low- to the high-estrogen phase (p = 0.023) and increased from the high-estrogen to the high-estrogen–progesterone phase (p = 0.006). FORD showed an opposite but non-significant trend. The FORT/FORD ratio decreased from the low- to the high-estrogen phase (p = 0.0104) and increased from the high-estrogen to the high-estrogen –progesterone phase (p = 0.004). Body temperature (n = 7) decreased in the high-estrogen phase (p = 0.001) and increased from the high-estrogen to the high-estrogen–progesterone phase (p = 0.001). In the seven women, FORT (p = 0.009) and FORT/FORD (p = 0.0056) were linearly related to body temperature values. Our data show opposite effects of estrogen and progesterone on oxidative status. These effects seem to be related to the effect exerted on body temperature regulation.

1 September 1999 in Fertility and Sterility
Verified
Journal Article
Closed access
PDF file
APAnna Maria Paoletti
Anna Maria Paoletti
ACAngelo Cagnacci
Angelo Cagnacci
MOMarisa Orrù
Marisa Orrù
SASilvia Ajossa
Silvia Ajossa
SGStefano Guerriero
Stefano Guerriero
GMGian Benedetto Melis
Gian Benedetto Melis

29 June 2008 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
CMCinzia Murgia
Cinzia Murgia
MOMarisa Orrù
Marisa Orrù
EPElaine Portoghese
Elaine Portoghese
NGNicoletta Garau
Nicoletta Garau
PZPierina Zedda
Pierina Zedda
GMGian Benedetto Melis
Gian Benedetto Melis
We previously reported a high prevalence (22.3%) of gestational diabetes mellitus (GDM) in a large group of Sardinian women, in contrast with the prevalence of Type 2 diabetes. Sardinia has an unusual distribution of haplotypes and genotypes, with the highest population frequency of HLA DR3 in the world, and after Finland, the highest prevalence of Type 1 diabetes and Autoimmune-related Diseases. In this study we preliminarily tested the prevalence of serological markers of Type 1 diabetes in a group of Sardinian GDM patients.